A detailed history of Baillie Gifford & CO transactions in Albemarle Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 2,404,910 shares of ALB stock, worth $262 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,404,910
Previous 2,476,488 2.89%
Holding current value
$262 Million
Previous $237 Million 3.71%
% of portfolio
0.17%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$72.85 - $100.09 $5.21 Million - $7.16 Million
-71,578 Reduced 2.89%
2,404,910 $228 Million
Q2 2024

Jul 25, 2024

BUY
$92.77 - $135.46 $401,972 - $586,948
4,333 Added 0.18%
2,476,488 $237 Million
Q1 2024

May 01, 2024

BUY
$108.73 - $146.89 $12.6 Million - $17.1 Million
116,284 Added 4.94%
2,472,155 $326 Million
Q4 2023

Jan 26, 2024

SELL
$113.26 - $170.8 $9.43 Million - $14.2 Million
-83,301 Reduced 3.42%
2,355,871 $340 Million
Q3 2023

Nov 13, 2023

SELL
$162.63 - $243.44 $8.95 Million - $13.4 Million
-55,058 Reduced 2.21%
2,439,172 $415 Million
Q2 2023

Jul 28, 2023

SELL
$172.91 - $232.22 $8.02 Million - $10.8 Million
-46,377 Reduced 1.83%
2,494,230 $556 Million
Q1 2023

May 03, 2023

SELL
$208.49 - $290.15 $34.2 Million - $47.6 Million
-164,109 Reduced 6.07%
2,540,607 $562 Million
Q4 2022

Jan 24, 2023

SELL
$214.02 - $325.38 $109 Million - $166 Million
-510,301 Reduced 15.87%
2,704,716 $587 Million
Q3 2022

Oct 27, 2022

SELL
$195.82 - $307.05 $137 Million - $215 Million
-701,352 Reduced 17.91%
3,215,017 $850 Million
Q2 2022

Aug 08, 2022

SELL
$187.76 - $270.92 $29.9 Million - $43.2 Million
-159,402 Reduced 3.91%
3,916,369 $818 Million
Q1 2022

May 05, 2022

SELL
$172.09 - $246.0 $64.2 Million - $91.7 Million
-372,838 Reduced 8.38%
4,075,771 $901 Million
Q4 2021

Jan 20, 2022

SELL
$214.16 - $283.8 $27.5 Million - $36.4 Million
-128,391 Reduced 2.81%
4,448,609 $1.04 Billion
Q3 2021

Oct 19, 2021

SELL
$167.91 - $244.03 $7.92 Million - $11.5 Million
-47,140 Reduced 1.02%
4,577,000 $1 Billion
Q2 2021

Aug 02, 2021

SELL
$143.7 - $176.01 $451,649 - $553,199
-3,143 Reduced 0.07%
4,624,140 $779 Million
Q1 2021

May 06, 2021

BUY
$140.69 - $185.25 $60.7 Million - $79.9 Million
431,127 Added 10.27%
4,627,283 $676 Million
Q4 2020

Feb 10, 2021

SELL
$86.73 - $149.91 $11.9 Million - $20.6 Million
-137,147 Reduced 3.16%
4,196,156 $619 Million
Q3 2020

Nov 12, 2020

SELL
$75.75 - $100.45 $6.66 Million - $8.83 Million
-87,912 Reduced 1.99%
4,333,303 $387 Million
Q2 2020

Aug 12, 2020

BUY
$52.7 - $86.74 $2.13 Million - $3.5 Million
40,373 Added 0.92%
4,421,215 $341 Million
Q1 2020

May 08, 2020

SELL
$50.9 - $94.31 $3.06 Million - $5.67 Million
-60,165 Reduced 1.35%
4,380,842 $247 Million
Q4 2019

Feb 10, 2020

BUY
$60.74 - $73.04 $9.61 Million - $11.6 Million
158,215 Added 3.69%
4,441,007 $324 Million
Q3 2019

Nov 07, 2019

BUY
$59.3 - $75.53 $94.7 Million - $121 Million
1,597,079 Added 59.47%
4,282,792 $298 Million
Q2 2019

Aug 08, 2019

BUY
$63.3 - $86.94 $2.9 Million - $3.98 Million
45,809 Added 1.74%
2,685,713 $189 Million
Q1 2019

May 01, 2019

BUY
$72.69 - $92.28 $282,982 - $359,246
3,893 Added 0.15%
2,639,904 $0
Q4 2018

Feb 14, 2019

BUY
$73.13 - $107.99 $986,304 - $1.46 Million
13,487 Added 0.51%
2,636,011 $203 Million
Q3 2018

Nov 13, 2018

BUY
$90.9 - $106.6 $470,407 - $551,655
5,175 Added 0.2%
2,622,524 $262 Million
Q2 2018

Jul 17, 2018

BUY
$88.96 - $104.92 $215 Million - $254 Million
2,419,144 Added 1220.53%
2,617,349 $247 Million
Q1 2018

May 10, 2018

BUY
$89.56 - $137.45 $518,910 - $796,385
5,794 Added 3.01%
198,205 $18.4 Million
Q4 2017

Feb 13, 2018

BUY
$127.48 - $144.58 $123,910 - $140,531
972 Added 0.51%
192,411 $24.6 Million
Q3 2017

Oct 20, 2017

BUY
$109.36 - $136.31 $752,834 - $938,358
6,884 Added 3.73%
191,439 $26.1 Million
Q2 2017

Aug 10, 2017

BUY
N/A
184,555
184,555 $19.5 Million

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $12.8B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.